At least 19 profitable biotechs and pharmas are slated to release earnings this week, with four biotechs expecting 25% or greater jumps in EPS over the prior year's quarter. The Street expects The Medicines Co. (NASDAQ:MDCO), Celgene Corp. (NASDAQ:CELG), ViroPharma Inc. (NASDAQ:VPHM) and Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) to report increases in 2Q10 EPS of 229%, 43%, 35% and 25%, respectively, on revenue growth of 3%, 31%, 14% and 12%. Earlier this year, Medicines Co. said it expects SG